SEC Form 4 · accession 0001232524-18-000099
Jazz Pharmaceuticals plc · JAZZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Suzanne Sawochka Hooper
Officer — EVP & General Counsel
Period of report
May 11, 2018
Accepted (ET)
May 15, 2018 · 4:41 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001232524
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | May 11, 2018 | S | 7,500 | $165.00 | D | 30,747 | D | |
| Ordinary Shares | May 14, 2018 | M | 8,540 | $46.83 | A | 39,287 | D | |
| Ordinary Shares | May 14, 2018 | M | 1,691 | $59.13 | A | 40,978 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (right to buy)F1 | $46.83 | May 14, 2018 | M | 8,540 | D | — | Aug 8, 2022 | Ordinary Shares | 8,540 | 0 | D |
| Incentive Stock Option (right to buy)F2 | $59.13 | May 14, 2018 | M | 1,691 | D | — | Mar 4, 2023 | Ordinary Shares | 1,691 | 0 | D |
Explanation of responses
- F1This incentive stock option is part of an option award granted on August 9, 2012. The ordinary shares subject to the option award vested over 4 years from the vesting commencement date of August 9, 2012, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in 36 equal monthly installments thereafter and were fully vested as of August 9, 2016.
- F2This incentive stock option is part of an option award granted on March 5, 2013. The ordinary shares subject to the option award vested over 4 years from the vesting commencement date of March 5, 2013, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in 36 equal monthly installments thereafter and were fully vested as of March 5, 2017.